BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23826293)

  • 1. Mucosal application of gp140 encoding DNA polyplexes to different tissues results in altered immunological outcomes in mice.
    Mann JF; McKay PF; Arokiasamy S; Patel RK; Tregoning JS; Shattock RJ
    PLoS One; 2013; 8(6):e67412. PubMed ID: 23826293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses.
    McKay PF; Mann JF; Pattani A; Kett V; Aldon Y; King D; Malcolm RK; Shattock RJ
    J Control Release; 2017 Mar; 249():74-83. PubMed ID: 28115243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice.
    King DF; McKay PF; Mann JF; Jones CB; Shattock RJ
    PLoS One; 2015; 10(11):e0141557. PubMed ID: 26544970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines.
    Klein K; Mann JF; Rogers P; Shattock RJ
    J Control Release; 2014 Jun; 183():43-50. PubMed ID: 24657807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.
    Devito C; Zuber B; Schröder U; Benthin R; Okuda K; Broliden K; Wahren B; Hinkula J
    J Immunol; 2004 Dec; 173(11):7078-89. PubMed ID: 15557206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection.
    Mann JF; McKay PF; Arokiasamy S; Patel RK; Klein K; Shattock RJ
    J Control Release; 2013 Sep; 170(3):452-9. PubMed ID: 23774102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules.
    Eo SK; Gierynska M; Kamar AA; Rouse BT
    J Immunol; 2001 May; 166(9):5473-9. PubMed ID: 11313385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.
    Cristillo AD; Ferrari MG; Hudacik L; Lewis B; Galmin L; Bowen B; Thompson D; Petrovsky N; Markham P; Pal R
    J Gen Virol; 2011 Jan; 92(Pt 1):128-40. PubMed ID: 21169215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.
    Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L
    J Virol; 2021 May; 95(12):. PubMed ID: 33789991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses.
    Torrieri-Dramard L; Lambrecht B; Ferreira HL; Van den Berg T; Klatzmann D; Bellier B
    Mol Ther; 2011 Mar; 19(3):602-11. PubMed ID: 20959813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
    Yao XY; Yuan MM; Li DJ
    Methods; 2006 Feb; 38(2):124-32. PubMed ID: 16414267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen.
    McKay PF; Cope AV; Mann JF; Joseph S; Esteban M; Tatoud R; Carter D; Reed SG; Weber J; Shattock RJ
    PLoS One; 2014; 9(1):e84707. PubMed ID: 24465426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen.
    Jones DI; Pollara JJ; Johnson-Weaver BT; LaBranche CC; Montefiori DC; Pickup DJ; Permar SR; Abraham SN; Maddaloni M; Pascual DW; Staats HF
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
    Huang X; Liu L; Ren L; Qiu C; Wan Y; Xu J
    Vaccine; 2007 Dec; 25(52):8874-84. PubMed ID: 18061316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk.
    Fouda GG; Amos JD; Wilks AB; Pollara J; Ray CA; Chand A; Kunz EL; Liebl BE; Whitaker K; Carville A; Smith S; Colvin L; Pickup DJ; Staats HF; Overman G; Eutsey-Lloyd K; Parks R; Chen H; Labranche C; Barnett S; Tomaras GD; Ferrari G; Montefiori DC; Liao HX; Letvin NL; Haynes BF; Permar SR
    J Virol; 2013 Jun; 87(12):6986-99. PubMed ID: 23596289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response.
    Soboll G; Nelson KM; Leuthner ES; Clark RJ; Drape R; Macklin MD; Swain WF; Olsen CW; Lunn DP
    Vaccine; 2003 Jun; 21(21-22):3081-92. PubMed ID: 12798652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
    Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
    J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity.
    Kuo-Haller P; Cu Y; Blum J; Appleton JA; Saltzman WM
    Mol Pharm; 2010 Oct; 7(5):1585-95. PubMed ID: 20698574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.